US Tribunals Issue Five Patent and Trademark Rulings Involving Major Tech and Healthcare Companies

Several courts and the Patent Trial and Appeal Board issued rulings in intellectual-property disputes. The Federal Circuit upheld a finding that claims in Zentian’s speech-recognition patent were obvious, while the board separately found claims in Willow Blossom and Willow Innovations’ wearable breast-pump patent obvious over prior art. In other patent cases, courts granted Teva and Apotex summary judgment of non-infringement in a dispute over tasimelteon treatment methods and approved a consent judgment resolving Momcozy’s breast-pump patent dispute with Chiaro, with the parties releasing their claims. A North Carolina court also ruled that consumers were unlikely to confuse Sturm, Ruger’s “Sfar” firearm mark with FN’s “Scar” mark.
Apple brought the inter partes review of Zentian’s speech-recognition patent; the Federal Circuit said Zentian had not shown that the PTAB erred in its claim construction.
The PTAB found Willow’s breast-pump claims obvious over combinations of prior art that included a breastshield unit, a system for expressing human breast milk, and a vented breast-fitting funnel.
In the tasimelteon case, the court concluded Teva and Apotex neither practiced the claimed treatment methods nor induced or contributorily infringed them.
The Momcozy–Chiaro consent judgment released not only patent-infringement claims but also claims involving breach of contract, tortious interference, and unfair competition.
Publishers
15
Articles
18
Reach
33